Clariant Relaunches Anti-Ageing Ingredient RedSnow
Clariant has relaunched its anti-ageing ingredient RedSnow after skin explant and clinical tests showed it to be effective in combating the negative effects of air pollution on skin.
Particulate matter from heavy metals, polycyclic aromatic hydrocarbons (PAHs) and greenhouse gasses can trigger biological responses including the aryl hydrocarbon receptor (AhR), which induces noxious reactive oxygen species (ROS).
Pollutants also stimulate the production of ROS via the NADPH oxidase (NOX) activation pathway.
RedSnow, an extract of the red Camellia japonica flower, was shown to have positive broad-spectrum antioxidant properties against the destructive impact of air pollution.
Another study revealed that both the AhR pathway and the NOX pathway were influenced by RedSnow.
A four-week human study found 2% RedSnow applied twice daily resulted in a 19% reduction in roughness.
Röchling Expanding Its Medical Division
2026-10-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Clariant Wins Catalyst Contract for World’s Largest Propane Dehydrogenation Unit
-
Exit! Why Did Clariant Divest Its Venezuelan Business at a “Low Price”?
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
Clariant and Shanghai Electric Partner to Advance Biomass-Based Green Methanol in China
-
Clariant’s New Aristoflex SUN for Advanced Sunscreen Formulations
-
Lugman Group Exits Acquisition of Clariant's 'Industrial Park Fechenheim'
-
TER Chemicals and Clariant Expand Distribution Partnership into Central and Eastern Europe
-
Clariant achieves 100% PFAS-free additive portfolio
-
Lucas Meyer Cosmetics by Clariant Opens New Beauty ColLABoration House Near Los Angeles
Recommend Reading
-
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
-
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
Supply-side Contraction, Inventory Supports Stable Price Operations
-
Business Society’s PTA Market Outlook on August 27, 2026: Volatile
-
Business Society’s Market Outlook for Ethyl Acetate on September 2, 2026: Clearly Upward Trend
-
Supply Reduction, Rising Costs, DOP Price Increase
-
Business Society’s Market Outlook for Polyester Staple Fiber on August 26, 2026: Volatile